Summit Therapeutics Inc. (SMMT)
NASDAQ · Manufacturing · Pharmaceutical preparations
$15.65−$0.7300 (−4.46%) on the dayAs of the close; data may be delayed.
SMMT price, last 12 months
Key stats
- Previous close
- $16.38
- Open
- $16.45
- Day range
- $15.55 – $16.67
- 52-week range
- $12.07 – $29.23
- Volume
- 3.5M
- Avg volume (20 days)
- 6.1M
- Market cap
- $12.5B
Performance
1W−12.3%
1M+10.0%
3M+11.7%
6M−9.3%
YTD−10.5%
1Y−23.7%
vs S&P 500, 1Y−40.4 pts
Technicals and fundamentals
About Summit Therapeutics Inc.
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $12.5B